| Literature DB >> 29516950 |
Guanghong Han1, Chengbi Xu2, Dan Yu2.
Abstract
Tongue cancer is one of the most common and deadly types of head and neck cancer. The incidence of tongue cancer has been particularly high and remained been increasing in some countries. A main reason for poor prognosis and clinical outcome for tongue cancer was its resistance to chemotherapies, behind which the mechanisms have been not clear. In this review, we summarized literatures published in recent years and listed the proteins, biomacromolecules, and signaling pathways related to this drug resistance. We hoped that this summary could provide reference for researchers to develop new treatment strategies for tongue cancer.Entities:
Keywords: Resistance; tongue cancer; treatment
Mesh:
Substances:
Year: 2018 PMID: 29516950 DOI: 10.4103/jcrt.JCRT_763_17
Source DB: PubMed Journal: J Cancer Res Ther ISSN: 1998-4138 Impact factor: 1.805